Furthermore, the down-regulation of hERG channel protein abundance and activity in rhabdomyosarcoma RD cells by treatment with the B-RAF inhibitor PLX-4720 points to a role of B-RAF in the regulation of hERG channels in those tumor cells. This evidence concerns the gene BRAF and neoplasm.